Table 2.
Patient characteristics in the training and external validation cohorts.
Training cohort | External validation cohort | p value | |
---|---|---|---|
Age (years) | 57.81 ± 10.13 | 55.86 ± 10.74 | 0.68 |
Sex (n, %) | 0.65 | ||
Male | 119 (55.9) | 89 (53.0) | |
Female | 94 (44.1) | 79 (47.0) | |
Tumor size (cm) | 5.45 ± 1.67 | 4.87 ± 1.62 | 0.72 |
Risk classification (n, %) | 0.63 | ||
Very low and low risk | 96 (45.1) | 82 (48.8) | |
Intermediate risk | 60 (28.2) | 48 (28.6) | |
High risk | 57 (26.7) | 38 (22.6) | |
Site (n, %) | 0.48 | ||
Gastric | 85 (39.9) | 74 (44.0) | |
Intestinal | 128 (60.1) | 94 (66.0) |
p < 0.05 indicates that difference is statistically significant.